Population Effects of Influenza A(H1N1) Pandemic among Health Plan Members, San Diego, California, USA, October-December 2009

Emerg Infect Dis. 2016 Feb;22(2):255-60. doi: 10.3201/eid2202.150618.

Abstract

Lacking population-specific data, activity of seasonal and pandemic influenza is usually tracked by counting the number of diagnoses and visits to medical facilities above a baseline. This type of data does not address the delivery of services in a specific population. To provide population-specific data, this retrospective study of patients with influenza-like illness, influenza, and pneumonia among members of a Kaiser Permanente health plan in San Diego, California, USA, during October-December 2009 was initiated. Population data included the number of outpatients accessing healthcare; the number of patients diagnosed with pneumonia; antimicrobial therapy administered; number of patients hospitalized with influenza, influenza-like illness, or pneumonia; level of care provided; and number of patients requiring specialized treatments (e.g., oxygen, ventilation, vasopressors). The rate of admissions specific to weeks and predictions of 2 epidemiologic models shows the strengths and weaknesses of those tools. Data collected in this study may improve planning for influenza pandemics.

Keywords: 2009; H1N1; Influenza A virus; ambulatory care; anti-infective agents; antimicrobial; antiviral; health planning; healthcare delivery; hospitalization; influenza A(H1N1)pdm09; inpatients; intensive care units; oseltamivir; pandemic; pandemics; pdm2009; pneumonia; population dynamics; population-based planning; positive pressure respiration; telemetry; vasoconstrictor; ventilation; viruses.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Ambulatory Care
  • Antiviral Agents / therapeutic use
  • California / epidemiology
  • Child
  • Child, Preschool
  • Cross Infection / epidemiology
  • Cross Infection / virology
  • Female
  • Health Personnel*
  • Humans
  • Infant
  • Infant, Newborn
  • Influenza A Virus, H1N1 Subtype*
  • Influenza, Human / drug therapy
  • Influenza, Human / epidemiology*
  • Influenza, Human / virology*
  • Inpatients
  • Male
  • Middle Aged
  • Seasons
  • Young Adult

Substances

  • Antiviral Agents